Application of A beta1-42 in preparation of preeclampsia treatment medicine or diagnostic kit
The invention relates to the technical field of biomedical engineering, discloses application of an A beta 1-42 inhibitor in preparation of an anti-preeclampsia drug, an A beta 1-42 inhibitor recombinant vector and application of the A beta 1-42 inhibitor recombinant vector in preparation of the ant...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
03.10.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to the technical field of biomedical engineering, discloses application of an A beta 1-42 inhibitor in preparation of an anti-preeclampsia drug, an A beta 1-42 inhibitor recombinant vector and application of the A beta 1-42 inhibitor recombinant vector in preparation of the anti-preeclampsia drug, and further provides application of a reagent for detecting the content of A beta 1-42 in preparation of a preeclampsia diagnostic kit. The invention further provides an anti-eclampsia pharmaceutical composition and a pre-eclampsia diagnosis kit. Based on the research on PE placenta and TM stimulated HTR-8/SVneo cells, the expression of A beta 1-42 in the samples is relatively high. Therefore, the accuracy and sensitivity of the PE can be improved by detecting the level of Abeta1-42, and a better scheme is provided for treatment and management of the PE.
本发明涉及生物医药工程技术领域,Aβ1-42抑制剂在制备抗子痫前期药物中的用途、Aβ1-42抑制剂重组载体及其在制备抗子痫前期药物中的用途,还提供了检测Aβ1-42含量的试剂在制备子痫前期诊断试剂盒中的用途,并进一步提供了抗子痫药物组合物和子痫前期诊断试剂盒。本发明基于对PE胎盘和被 |
---|---|
Bibliography: | Application Number: CN202310246837 |